Hosted on MSN
Merck's Keytruda gets new FDA approval for expanded use in pretreated ovarian cancer patients
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s MRK Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) plus paclitaxel, ...
(RTTNews) - Merck & Co Inc. (MRK) on Wednesday said the U.S. Food and Drug Administration has approved Keytruda and Keytruda Qlx, a subcutaneous formulation of Keytruda, in combination with paclitaxel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results